The test works by identifying the presence of two proteins in cells of the original cancer
Experts are calling on policymakers to acknowledge and accommodate the risks of femtech technologies in the relevant regulations
Nearly two thirds of patients treated with dostarlimab alongside standard chemotherapy had not seen their cancer progress after 12 months of treatment
Getting a diagnosis for endometriosis in the UK now takes almost a year longer than before the pandemic
Campaigners have warned that health tools could overlook women from marginalised communities
Talking therapies could reduce symptoms that may not be otherwise relieved through HRT, specialists have argued
More than 60 per cent of respondents saw three or more healthcare providers to get a diagnosis, research has found
One in five women feel their workplaces are unsupportive of chronic health conditions
Perelel aims to close the divide on women's reproductive health research and improve access to nutritional support
A new type of immunotherapy could lead to pioneering treatment for breast cancer
